HOME >> BIOLOGY >> NEWS
Secondary complications and restoration of function in SCI

>

Variable-frequency-train (VFT) stimulation has received considerable interest for countering the fatigue that occurs in the muscles of able-bodied individuals during functional electrical stimulation. There is also much interest in using electrical stimulation for the rehabilitation of individuals with SCI. This study investigated the effectiveness of VFT stimulation on reducing quadriceps muscle fatigue in persons with complete SCI. The data provide the first evidence that VFT stimulation may not be effective at reducing fatigue without prior conditioning with electrical stimulation. The results may lead to an improved clinical use of electrical stimulation.

Portable neuromuscular stimulator aids exercise and mobility for individuals with paraplegia (pg 41)

Over the past 25 years, functional electrical stimulation has become a viable rehabilitative tool for the paraplegic population. The design and development of a portable, neuromuscular stimulator for use by individuals with paraplegia is described in this article. Potential uses of the neuromuscular stimulator include exercise, mobility and preventive skin care. The stimulator passed all relevant safety and reliability testing, making it suitable for home use.

Neostigmine and glycopyrrolate promote bowel movement (pg 53)

This study assessed the effects of neostigmine alone or neostigmine combined with glycopyrrolate on pulmonary suppression in individuals with SCI. The data suggest that although neostigmine promoted bowel movement, it also caused bronchoconstriction, which may worsen a weak respiratory system. When neostigmine is combined with glycopyrrolate, bowel movement is facilitated while bronchoconstriction is prevented. For patients with SCI who require bowel evacuation assistance, neostigmine and glycopyrrolate should be administered in combination.

Bronchodilator responses to metaproterenol sulfate among subjects with spinal cord injury (pg 59)<
'"/>

Contact: Judith LaVoie
judith@vard.org
410-962-1800 x 229
VA Research Communications Service
20-Feb-2004


Page: 1 2 3 4 5

Related biology news :

1. Women who drink may be at greater risk of cardiovascular complications than men
2. Remote monitoring of ICU patients lowers mortality rates, complications
3. Fetal and birth complications increase mental illness risks
4. Substance used to treat complications from diabetes also proves to work as antioxidant
5. Bush signs; ozone treatment for ballast water; wetland restoration template goes national
6. Traditional floodplain forest restoration may decrease bird diversity
7. Answers to Florida bay restoration are clear as mud!
8. Wave of the future? Dams as river restoration
9. Experts meet to evaluate watershed restoration for salmon in Pacific rivers
10. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
11. Fossil genes reveal how life sheds form and function

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Secondary complications and restoration function SCI

(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience technology company ... system, announced today a partnership with eight-time All-Star, ... to develop a new mobile app designed for professional and ... performance. Vision is the inception of every move ... or blocking a pass. The critical impact vision speed has ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, a leader in ... is to open in Manhattan, Kansas in early October, 2015. The location of ... research and development through collaboration with researchers from Kansas State University’s College of ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... 26, 2015 Despite recent ... the optimism in biotech,s forecast is the recent ... sciences advancements.  Active biotechnology & healthcare companies with ... (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: SQNM ), ... Pharmaceutical Corp. (NASDAQ: RPTP ) and EnteroMedics ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
Cached News: